These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11834961)

  • 21. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of avascular necrosis and HIV.
    Plate AM; Boyle BA
    AIDS Read; 2000 Oct; 10(10):570-3. PubMed ID: 11068790
    [No Abstract]   [Full Text] [Related]  

  • 23. Osteonecrosis in HIV: a case-control study.
    Scribner AN; Troia-Cancio PV; Cox BA; Marcantonio D; Hamid F; Keiser P; Levi M; Allen B; Murphy K; Jones RE; Skiest DJ
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):19-25. PubMed ID: 11064500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain.
    Gutiérrez F; Padilla S; Masiá M; Flores J; Boix V; Merino E; Galindo J; Ortega E; López-Aldeguer J; Galera C;
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):286-92. PubMed ID: 16763523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gynaecomastia in HIV-infected men: association with effects of antiretroviral therapy.
    Paech V; Lorenzen T; von Krosigk A; Graefe K; Stoehr A; Plettenberg A
    AIDS; 2002 May; 16(8):1193-5. PubMed ID: 12004284
    [No Abstract]   [Full Text] [Related]  

  • 26. Avascular necrosis in HIV infection.
    Johns DG; Gill MJ
    AIDS; 1999 Oct; 13(14):1997-8. PubMed ID: 10513672
    [No Abstract]   [Full Text] [Related]  

  • 27. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management.
    Allison GT; Bostrom MP; Glesby MJ
    AIDS; 2003 Jan; 17(1):1-9. PubMed ID: 12478064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk associated with HIV therapy.
    Currier JS
    J Acquir Immune Defic Syndr; 2002 Sep; 31 Suppl 1():S16-23; discussion S24-5. PubMed ID: 12218440
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease.
    Ribera JM; Navarro JT; Oriol A; López-Guillermo A; Sureda A; Abella E; Hernández-Rivas JA; Xicoy B; Grau J; Batlle M; Feliu E
    AIDS; 2002 Sep; 16(14):1973-6. PubMed ID: 12351963
    [No Abstract]   [Full Text] [Related]  

  • 30. Complications and side effects. French researchers study bone disease.
    TreatmentUpdate; 2005 Mar; 17(2):3-4. PubMed ID: 17228463
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.
    Gaughan DM; Mofenson LM; Hughes MD; Seage GR; Ciupak GL; Oleske JM;
    Pediatrics; 2002 May; 109(5):E74-4. PubMed ID: 11986480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mass in HIV-infected patients: focus on the role of therapy and sex.
    Vescini F; Borderi M; Buffa A; Sinicropi G; Tampellini L; Chiodo F; Caudarella R
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):405-7. PubMed ID: 12843753
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
    Mary-Krause M; Billaud E; Poizot-Martin I; Simon A; Dhiver C; Dupont C; Salmon D; Roudiere L; Costagliola D;
    AIDS; 2006 Aug; 20(12):1627-35. PubMed ID: 16868444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic and skeletal complications of HIV infection: the price of success.
    Morse CG; Kovacs JA
    JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of osteonecrosis and osteoporosis in HIV-1-infected patients.
    Fessel WJ; Chau Q; Leong D
    AIDS; 2011 Sep; 25(15):1877-80. PubMed ID: 21785318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vertebral osteonecrosis in an HIV-infected patient.
    Sifuentes Giraldo WA; Macía Villa CC; Rodríguez-Navarro CQ; Vázquez Díaz M
    Antivir Ther; 2012; 17(8):1627-30. PubMed ID: 22869279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone disorders, hypertension, and mitochondrial toxicity in HIV disease.
    Newman MD
    Top HIV Med; 2003; 11(1):10-5. PubMed ID: 12717045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
    Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS
    Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone disease and HIV infection.
    Rojo P; Ramos JT
    Clin Infect Dis; 2006 Jul; 43(1):111-2; author reply 113-4. PubMed ID: 16758430
    [No Abstract]   [Full Text] [Related]  

  • 40. Concomitant presentation of multiple vertebral and peripheral osteonecrosis in a HIV-infected patient.
    Sifuentes Giraldo WA; Blázquez Cañamero M; Navas Elorza E; Gallego Rivera I; Vázquez Díaz M
    Joint Bone Spine; 2012 May; 79(3):332-4. PubMed ID: 22281227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.